ProShare Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-75,252
| Closed | -$229K | – | 2283 |
|
|
2024
Q4 | $229K | Buy |
75,252
+12,155
| +19% | +$37K | ﹤0.01% | 1820 |
|
|
2024
Q3 | $327K | Buy |
63,097
+44,940
| +248% | +$233K | ﹤0.01% | 1407 |
|
|
2024
Q2 | $46.7K | Sell |
18,157
-3,747
| -17% | -$9.63K | ﹤0.01% | 1760 |
|
|
2024
Q1 | $108K | Buy |
21,904
+1,809
| +9% | +$8.9K | ﹤0.01% | 1810 |
|
|
2023
Q4 | $177K | Buy |
20,095
+3,509
| +21% | +$30.8K | ﹤0.01% | 1670 |
|
|
2023
Q3 | $190K | Buy |
16,586
+298
| +2% | +$3.42K | ﹤0.01% | 1487 |
|
|
2023
Q2 | $412K | Buy |
16,288
+1,045
| +7% | +$26.4K | ﹤0.01% | 1065 |
|
|
2023
Q1 | $491K | Sell |
15,243
-1,950
| -11% | -$62.8K | ﹤0.01% | 916 |
|
|
2022
Q4 | $317K | Buy |
17,193
+3,136
| +22% | +$57.9K | ﹤0.01% | 1205 |
|
|
2022
Q3 | $379K | Buy |
14,057
+516
| +4% | +$13.9K | ﹤0.01% | 1023 |
|
|
2022
Q2 | $187K | Sell |
13,541
-7,015
| -34% | -$96.9K | ﹤0.01% | 1493 |
|
|
2022
Q1 | $400K | Sell |
20,556
-4,869
| -19% | -$94.7K | ﹤0.01% | 1441 |
|
|
2021
Q4 | $414K | Buy |
25,425
+1,085
| +4% | +$17.7K | ﹤0.01% | 1586 |
|
|
2021
Q3 | $678K | Sell |
24,340
-6,722
| -22% | -$187K | ﹤0.01% | 1049 |
|
|
2021
Q2 | $921K | Buy |
31,062
+4,385
| +16% | +$130K | ﹤0.01% | 1085 |
|
|
2021
Q1 | $746K | Buy |
26,677
+2,467
| +10% | +$69K | ﹤0.01% | 1173 |
|
|
2020
Q4 | $686K | Buy |
24,210
+5,872
| +32% | +$166K | ﹤0.01% | 1076 |
|
|
2020
Q3 | $461K | Buy |
18,338
+1,504
| +9% | +$37.8K | ﹤0.01% | 980 |
|
|
2020
Q2 | $411K | Buy |
16,834
+6,712
| +66% | +$164K | ﹤0.01% | 1053 |
|
|
2020
Q1 | $150K | Sell |
10,122
-5,751
| -36% | -$85.2K | ﹤0.01% | 1038 |
|
|
2019
Q4 | $258K | Sell |
15,873
-1,081
| -6% | -$17.6K | ﹤0.01% | 1435 |
|
|
2019
Q3 | $220K | Buy |
16,954
+59
| +0.3% | +$766 | ﹤0.01% | 1393 |
|
|
2019
Q2 | $219K | Sell |
16,895
-2,219
| -12% | -$28.8K | ﹤0.01% | 1389 |
|
|
2019
Q1 | $301K | Buy |
19,114
+3,120
| +20% | +$49.1K | ﹤0.01% | 1258 |
|
|
2018
Q4 | $322K | Sell |
15,994
-3,084
| -16% | -$62.1K | ﹤0.01% | 1114 |
|
|
2018
Q3 | $474K | Sell |
19,078
-703
| -4% | -$17.5K | ﹤0.01% | 1132 |
|
|
2018
Q2 | $543K | Sell |
19,781
-526
| -3% | -$14.4K | ﹤0.01% | 1072 |
|
|
2018
Q1 | $625K | Buy |
20,307
+238
| +1% | +$7.33K | ﹤0.01% | 1016 |
|
|
2017
Q4 | $717K | Buy |
20,069
+1,171
| +6% | +$41.8K | 0.01% | 974 |
|
|
2017
Q3 | $521K | Buy |
18,898
+1,377
| +8% | +$38K | ﹤0.01% | 947 |
|
|
2017
Q2 | $463K | Sell |
17,521
-482
| -3% | -$12.7K | ﹤0.01% | 986 |
|
|
2017
Q1 | $374K | Sell |
18,003
-4,121
| -19% | -$85.6K | ﹤0.01% | 1133 |
|
|
2016
Q4 | $458K | Buy |
22,124
+2,139
| +11% | +$44.3K | 0.01% | 1122 |
|
|
2016
Q3 | $324K | Sell |
19,985
-3,703
| -16% | -$60K | ﹤0.01% | 1118 |
|
|
2016
Q2 | $322K | Buy |
23,688
+670
| +3% | +$9.11K | ﹤0.01% | 1173 |
|
|
2016
Q1 | $402K | Sell |
23,018
-2,218
| -9% | -$38.7K | 0.01% | 1088 |
|
|
2015
Q4 | $862K | Buy |
25,236
+5,474
| +28% | +$187K | 0.01% | 808 |
|
|
2015
Q3 | $588K | Sell |
19,762
-1,344
| -6% | -$40K | 0.01% | 880 |
|
|
2015
Q2 | $675K | Buy |
21,106
+331
| +2% | +$10.6K | 0.01% | 963 |
|
|
2015
Q1 | $431K | Buy |
20,775
+3,231
| +18% | +$67K | 0.01% | 1259 |
|
|
2014
Q4 | $297K | Buy |
+17,544
| New | +$297K | ﹤0.01% | 1517 |
|